PlexusDx provides ongoing support to help you navigate plateaus and optimize your results as your body responds to sustained GLP-1 therapy
Multiple peptides hitting different mechanisms at the same time
Tepezza, approved by the FDA in 2020, is used to treat Thyroid Eye Disease (TED), but some patients have reported hearing issues after its use
But some feedback also mentions common problems, like treatment discontinuation
Yes, it supports longer workout sessions by helping your body use energy more efficiently
Research has identified specific risk factors that increase your likelihood of developing telogen effluvium: Speed of Weight Loss Studies consistently show that losing more than 1-2 pounds per week, especially sustained over several weeks, significantly increases risk